SEARCH

SEARCH BY CITATION

References

  • 1
    Forman D. Counting cancers at the junction: a problem of routine statistics. Eur J Gastroenterol Hepatol 2002; 14: 99102.DOI: 10.1097/00042737-200202000-00001
  • 2
    Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998; 85: 14579.DOI: 10.1046/j.1365-2168.1998.00940.x
  • 3
    Ekstrom AM, Signorello LB, Hansson LE, Bergstrom R, Lindgren A, Nyren O. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst 1999; 91: 78690.DOI: 10.1093/jnci/91.9.786
  • 4
    Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J Am Med Assoc 1991; 265: 12879.
  • 5
    Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 204953.
  • 6
    Botterweck AA, Schouten LJ, Volovics A, Dorant E, Can Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 64554.
  • 7
    Vizcaino AP, Moreno V, Lambert R, Parkin DM. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995. Int J Cancer 2002; 99: 8608.DOI: 10.1002/ijc.10427
  • 8
    Wijnhoven BPL, Louwman MWJ, Tilanus HW, Coebergh JW. Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 2002; 14: 11522.DOI: 10.1097/00042737-200202000-00004
  • 9
    Brewster DH, Fraser LA, McKinney PA, Black RJ. Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland [2000]. Br J Cancer 2000; 83: 38790.
  • 10
    Parkin DM, Whelan SL, Ferlay J, et al. Cancer Incidence in Five Continents, Vol. VIII, IARC Scientific Publication No 155. Lyon: IARC, 2002.
  • 11
    Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol and socio-economic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997; 89: 127784.DOI: 10.1093/jnci/89.17.1277
  • 12
    Chen H, Tucker KL, Graubard BI, et al. Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer 2002; 42: 3340.
  • 13
    Mayne ST, Risch HA, Dubrow R, et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 2001; 10: 105562.
  • 14
    Iijima K, Henry E, Moriya A, Wirz A, Kelman AW, McColl KE. Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. Gastroenterology 2002; 122: 124857.
  • 15
    Farrow DC, Vaughan TL, Hansten PD, et al. Use of aspirin and other non-steroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998; 7: 97102.
  • 16
    Wu A, Wan P, Bernstein L. A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinoma of the stomach and esophagus (United States). Cancer Causes Control 2001; 12: 72132.DOI: 10.1023/A:1011290704728
  • 17
    Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998; 90: 1505.
  • 18
    Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 1999; 130: 88390.
  • 19
    Farrow DC, Vaughan TL, Sweeney C, et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000; 11: 2318.DOI: 10.1023/A:1008913828105
  • 20
    Lagergren J, Bergström R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 82531.DOI: 10.1056/NEJM199903183401101
  • 21
    Wu AH, Tseng L-L, Bernstein L. Hiatal hernia, reflux symptoms, body size and risk of esophageal and gastric adenocarcinoma. Cancer 2003; 98: 9408.
  • 22
    Wilson LJ, Ma W, Hirschowitz BI. Association of obesity with hiatal hernia and esophagitis. Am J Gastroenterol 1999; 94: 28404.DOI: 10.1016/S0002-9270(99)00482-7
    Direct Link:
  • 23
    Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 1999; 106: 6429.DOI: 10.1016/S0002-9343(99)00121-7
  • 24
    Murray LJ. Relationship between body mass and gastro-oesophageal reflux symptoms. The Bristol Helicobacter Project. Int J Epidemiol 2003; 32: 64550.DOI: 10.1093/ije/dyg108
  • 25
    Lagergren J, Bergström R, Nyrén O. No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut 2000; 47: 269.DOI: 10.1136/gut.47.1.26
  • 26
    Burbige EJ, Radigan JJ. Characteristics of the columnar-cell lined (Barrett's) esophagus. Gastrointest Endosc 1979; 25: 1336.
  • 27
    Sarr MG, Hamilton SR, Marrone GC, Cameron JL. Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Am J Surg 1985; 149: 18793.
  • 28
    Yeh C, Hsu C, Ho A, Sampliner R, Fass R. Erosive esophagitis and Barrett's esophagus in Taiwan. A higher frequency than expected. Dig Dis Sci 1997; 42: 7026.DOI: 10.1023/A:1018835324210
  • 29
    Corder AP, Jones RH, Millward-Sadler GH, Daniels P, Johnson CD. Heartburn, oesophagitis and Barrett's oesophagus in self-medicating patients in general practice. Br J Clin Pract 1996; 50: 2458.
  • 30
    Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett's esophagus and esophageal cancer. J Am Med Assoc 2002; 287: 197281.DOI: 10.1001/jama.287.15.1972
  • 31
    Dulai GS, Guha S, Kahn KL, Gombein J, Weinstein WM. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 2002; 122: 2633.
  • 32
    Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 3338.
  • 33
    Jankowski JA, Provenzale D, Moayyedi P. Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west. Gastroenterology 2000; 122: 58890.
  • 34
    Spechler SJ. Barrett's esophagus: an overrated cancer risk factor. Gastroenterology 2000; 119: 5879.
  • 35
    Provenzale D, Schmitt C, Wong JB. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999; 94: 204353.DOI: 10.1016/S0002-9270(99)00332-9
    Direct Link:
  • 36
    Murray LJ, Watson RGP, Johnston BT, et al. Risk of adenocarcinoma in Barrett's oesophagus: results of a population-based study. Br Med J 2003; 327: 5345.
  • 37
    Wild CP, Hardie LJ. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 2003; 3: 67684.DOI: 10.1038/nrc1166
  • 38
    Bani-Hani K, Martin IG, Hardie LJ, et al. Prospective study of cyclin D1 overexpression in Barrett's esophagus: association with increased risk of adenocarcinoma. J Natl Cancer Inst 2000; 92: 131621.